25 Feature In one of the most highly anticipated decisions emanating from the apex Court in the US in recent times, the US Supreme Court in Association for Molecular Pathology

First Page		Document Content
Date: 2014-12-15 22:08:18 Biology Gene patent Biological patent Patentable subject matter Implications of US gene patent invalidation on Australia Title 35 of the United States Code Kirin-Amgen v Hoechst Marion Roussel Directive on the legal protection of biotechnological inventions Bilski v. Kappos Patent law Law Civil law		25 Feature In one of the most highly anticipated decisions emanating from the apex Court in the US in recent times, the US Supreme Court in Association for Molecular Pathology Add to Reading List Source URL: www.lawsociety.org.sg Download Document from Source Website File Size: 174,07 KB Share Document on Facebook

	Does Compulsory Licensing Discourage Invention? Evidence from German Patents after the US Trading-with-the-Enemy Act By Joerg Baten, Nicola Bianchi, and Petra Moser ABSTRACT Compulsory licensing – which allows patents DocID: 18PkX - View Document
	SUPREME COURT: GENES ARE NOT PATENTABLE June 2013 The ethical stance taken by HUGO over the years has suggested that the outcomes of genomic research should be used for the benefit of society. In its Statements on Benefi DocID: 17euG - View Document
	Submission to Review of the Innovation Patent System Brendan Molloy () Mozart Olbrycht-Palmer () Rodney Serkowski () DocID: 14xtn - View Document
	Biotechnology breathes a sigh of relief: Isolated gene sequences are patentable subject matter Intellectual Property Update Case note in Cancer Voices Australia v Myriad Genetics IncFCA 65. DocID: 145iy - View Document
	Submission to the Advisory Council on Intellectual Property in response to its Discussion Paper Review of Crown Use Provisions in Patents and Designs Legislation DocID: 12vWj - View Document